| 000 | 01419 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518093737.0 | ||
| 264 | 0 | _c20210616 | |
| 008 | 202106s 0 0 eng d | ||
| 022 | _a1618-7601 | ||
| 024 | 7 |
_a10.1007/s10198-020-01180-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTen Thoren, C | |
| 245 | 0 | 0 |
_aDetermination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer. _h[electronic resource] |
| 260 |
_bThe European journal of health economics : HEPAC : health economics in prevention and care _cAug 2020 |
||
| 300 |
_a881-893 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 |
_aDrug Approval _xmethods |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTechnology Assessment, Biomedical |
| 700 | 1 | _aBalg, C | |
| 700 | 1 | _aGibbert, J | |
| 700 | 1 | _aMostardt, S | |
| 700 | 1 | _aRipoll, M | |
| 700 | 1 | _aSchierbaum, D | |
| 700 | 1 | _aSchiller, S | |
| 700 | 1 | _aSchwalm, A | |
| 773 | 0 |
_tThe European journal of health economics : HEPAC : health economics in prevention and care _gvol. 21 _gno. 6 _gp. 881-893 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10198-020-01180-1 _zAvailable from publisher's website |
| 999 |
_c30804436 _d30804436 |
||